Table 4.

Logistic regression in relation to cardiovascular and renal impairment events.

Variables	Cardiovascular events			Renal impairment events
	Exp (beta)	95%CI	P value	Exp (beta)	95%CI	P value
Age (years)	1.027	0.65–1.61	0.907	1.006	0.97–1.03	0.670
Gender	1.159	1.13–1.18	0.005	1.147	0.63–1.85	0.646
Weight (kg)	0.983	0.94–1.02	0.377	1.015	0.97–1.05	0.451
BMI (kg/m2)	0.958	0.85–1.07	0.446	0.972	0.86–1.09	0.633
WC (cm)	1.031	0.99–1.07	0.119	1.009	0.96–1.05	0.707
Smoker (yes vs. no)	0.707	0.37–1.33	0.283	1.319	0.57–3.04	0.112
SBP (mmHg)	1016	0.98–1.04	0.293	1.033	0.99–1.07	0.071
DBP (mmHg)	0.981	0.92–1.03	0.514	0.941	0.87–1.01	0.122
Antihypertensive (yes vs. no)	1.283	0.63–2.61	0.492	1.067	0.41–2.76	0.894
FBS (mg/dL)	0.995	0.98–1.01	0.551	1.013	0.99–1.03	0.163
HbA1c (%)	1.033	0.99–1.07	0.071	0.954	0.74–1.27	0.013
DDM (years)	0.995	0.97–1.01	0.110	1.094	1.07–1.11	0.009
Oral hypoglycemia (yes vs. no)	2.709	0.65–3.27	0.171	0.305	0.04–2.09	0.228
Insulin therapy (yes vs. no)	1.984	0.50–3.82	0.327	0.321	0.05–1.96	0.219
T. cholesterol (mg/dL)	1.014	0.99–1.03	0.061	1.015	1.00–1.02	0.011
HDL-C (mg/dL)	0.982	0.95–1.01	0.237	0.970	0.92–1.02	0.250
LDL-C (mg/dL)	1.003	0.99–1.01	0.024	0.998	0.98–1.01	0.756
Triglyceride (mg/dL)	1.001	0.99–1.01	0.075	0.994	0.98–1.01	0.129
ALT (U/L)	0.999	0.99–1.01	0.806	1.010	0.98–1.03	0.429
AST (U/L)	1.003	0.96–1.04	0.867	0.992	0.96–1.02	0.651
MetS (yes vs. no)	0.800	0.36–1.77	0.127	1.070	0.39–2.93	0.085
MetS (mean)	0.864	0.57–1.30	0.108	0.638	0.39–1.02	0.078
NAFLD (yes vs. no)	5.210	1.93–4.25	<0.001	1.015	1.70–4.02	0.005